Trial Profile
Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 05 Nov 2015 New trial record